Concepedia

Richard N. Channick

RN

107

Publications

15.5K

Citations

57

H-Index

1993

Active since

Affiliations

University of California San Diego(Current)

Massachusetts General Hospital

Actelion (Switzerland)

The University of Texas Southwestern Medical Center

Université Paris-Sud

Richard N. Channick is an author at University of California San Diego specializing in medicine, pulmonary vascular disease, and public health.

Top concepts

MedicineCardiovascular DiseasePulmonary Vascular DiseasePublic HealthHypertensionAnesthesiologyPulmonary HypertensionPulmonary MedicinePulmonary EmbolismCardiology

Publications per year

1993–2024

107

Publications

107

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

Richard N. Channick, G Simonneau, Olivier Sitbon et al. · The Lancet · 2001 · 1.5K citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +10

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

Tomás Pulido, Igor Adzerikho, Richard N. Channick et al. · New England Journal of Medicine · 2013 · 1.4K citations · Full text

Selexipag for the Treatment of Pulmonary Arterial Hypertension

Olivier Sitbon, Richard N. Channick, Kelly Chin et al. · New England Journal of Medicine · 2015 · 1K citations · Full text

Pulmonary endarterectomy: experience and lessons learned in 1,500 cases

Stuart W. Jamieson, David P. Kapelanski, Naohide Sakakibara et al. · The Annals of Thoracic Surgery · 2003 · 762 citations

Interventional Pulmonology, Pulmonary Endarterectomy, Thoracic Surgery +5

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2

Marc Humbert, Robyn J. Barst, Ivan M. Robbins et al. · European Respiratory Journal · 2004 · 638 citations · Full text

Rows per page

1–5 of 107